AVCTAIM
Avacta Group
UK-listedFTSE AIM 100
The verified shareholder board for Avacta Group. Discuss Avacta Group (AVCT) with other verified holders — real people, considered discussion, and a collective voice the company has a reason to answer.
What shareholders are weighing
- The FDA has agreed on a pivotal trial design for AVA6000 and platform-validating data with Faridoxorubicin has been released — how do shareholders view the significance of these clinical and regulatory milestones for Avacta's near-term prospects?
- Following FDA agreement on the pivotal trial design for AVA6000 and the release of platform-validating data with Faridoxorubicin, how do shareholders view the clinical and regulatory progress and what does this mean for AVCT's development timeline?
Join the discussion
The Shareholders Board is a community of verified shareholders — real people, no bots, no anonymous accounts. Reading and joining the conversation about Avacta Group is for members.
Nothing on this page is investment advice or a recommendation to buy or sell any security. It is a place to discuss the companies you own with other verified owners.